nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A2—Progesterone—uterine cancer	0.161	0.23	CbGbCtD
Epinephrine—SLC22A1—Progesterone—uterine cancer	0.139	0.2	CbGbCtD
Epinephrine—SLC22A5—Dactinomycin—uterine cancer	0.134	0.191	CbGbCtD
Epinephrine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0665	0.0952	CbGbCtD
Epinephrine—CYP1A2—Progesterone—uterine cancer	0.0489	0.07	CbGbCtD
Epinephrine—CYP2C9—Progesterone—uterine cancer	0.044	0.0631	CbGbCtD
Epinephrine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0386	0.0553	CbGbCtD
Epinephrine—CYP3A4—Progesterone—uterine cancer	0.0256	0.0367	CbGbCtD
Epinephrine—CYP1A2—Etoposide—uterine cancer	0.0219	0.0313	CbGbCtD
Epinephrine—CYP3A4—Etoposide—uterine cancer	0.0115	0.0164	CbGbCtD
Epinephrine—CYP3A4—Doxorubicin—uterine cancer	0.00781	0.0112	CbGbCtD
Epinephrine—Extravasation—Carboplatin—uterine cancer	0.00496	0.0324	CcSEcCtD
Epinephrine—PAH—renal system—uterine cancer	0.00384	0.0598	CbGeAlD
Epinephrine—Cerebral haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.0243	CcSEcCtD
Epinephrine—TNF—vagina—uterine cancer	0.00369	0.0575	CbGeAlD
Epinephrine—Tachyarrhythmia—Epirubicin—uterine cancer	0.00357	0.0233	CcSEcCtD
Epinephrine—Skin necrosis—Etoposide—uterine cancer	0.00333	0.0217	CcSEcCtD
Epinephrine—Tachyarrhythmia—Doxorubicin—uterine cancer	0.0033	0.0215	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.0205	CcSEcCtD
Epinephrine—ADRBK1—smooth muscle tissue—uterine cancer	0.00304	0.0474	CbGeAlD
Epinephrine—ADRBK1—renal system—uterine cancer	0.00293	0.0456	CbGeAlD
Epinephrine—Memory impairment—Progesterone—uterine cancer	0.00289	0.0189	CcSEcCtD
Epinephrine—Lactic acidosis—Epirubicin—uterine cancer	0.00267	0.0174	CcSEcCtD
Epinephrine—Necrosis—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.0171	CcSEcCtD
Epinephrine—Lactic acidosis—Doxorubicin—uterine cancer	0.00247	0.0161	CcSEcCtD
Epinephrine—Drug interaction—Progesterone—uterine cancer	0.00245	0.016	CcSEcCtD
Epinephrine—Nephropathy—Etoposide—uterine cancer	0.00244	0.0159	CcSEcCtD
Epinephrine—ADRB3—female reproductive system—uterine cancer	0.0024	0.0374	CbGeAlD
Epinephrine—TNF—lymph node—uterine cancer	0.00239	0.0372	CbGeAlD
Epinephrine—ADRBK1—female reproductive system—uterine cancer	0.00235	0.0365	CbGeAlD
Epinephrine—Blood pressure increased—Progesterone—uterine cancer	0.00227	0.0148	CcSEcCtD
Epinephrine—Drug interaction—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.0145	CcSEcCtD
Epinephrine—ADRB3—female gonad—uterine cancer	0.00218	0.034	CbGeAlD
Epinephrine—ADRBK1—female gonad—uterine cancer	0.00213	0.0333	CbGeAlD
Epinephrine—ADRBK1—vagina—uterine cancer	0.00212	0.0331	CbGeAlD
Epinephrine—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.0134	CcSEcCtD
Epinephrine—Necrosis—Dactinomycin—uterine cancer	0.00205	0.0134	CcSEcCtD
Epinephrine—Lightheadedness—Progesterone—uterine cancer	0.00203	0.0133	CcSEcCtD
Epinephrine—Skin necrosis—Epirubicin—uterine cancer	0.00186	0.0122	CcSEcCtD
Epinephrine—Disorientation—Progesterone—uterine cancer	0.00184	0.012	CcSEcCtD
Epinephrine—Extravasation—Dactinomycin—uterine cancer	0.00184	0.012	CcSEcCtD
Epinephrine—Hemiplegia—Epirubicin—uterine cancer	0.00182	0.0119	CcSEcCtD
Epinephrine—ADRA1D—epithelium—uterine cancer	0.00182	0.0283	CbGeAlD
Epinephrine—SLC22A2—renal system—uterine cancer	0.0018	0.0281	CbGeAlD
Epinephrine—Skin necrosis—Doxorubicin—uterine cancer	0.00172	0.0113	CcSEcCtD
Epinephrine—ADRA1B—renal system—uterine cancer	0.00172	0.0269	CbGeAlD
Epinephrine—Hemiplegia—Doxorubicin—uterine cancer	0.00169	0.011	CcSEcCtD
Epinephrine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.01	CcSEcCtD
Epinephrine—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00995	CcSEcCtD
Epinephrine—Necrosis—Etoposide—uterine cancer	0.00148	0.00967	CcSEcCtD
Epinephrine—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00953	CcSEcCtD
Epinephrine—Tingling sensation—Etoposide—uterine cancer	0.00145	0.00944	CcSEcCtD
Epinephrine—Sweating increased—Progesterone—uterine cancer	0.00139	0.00906	CcSEcCtD
Epinephrine—ADRBK1—lymph node—uterine cancer	0.00137	0.0214	CbGeAlD
Epinephrine—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00888	CcSEcCtD
Epinephrine—ADRA1D—female reproductive system—uterine cancer	0.00135	0.021	CbGeAlD
Epinephrine—Extravasation—Etoposide—uterine cancer	0.00133	0.00869	CcSEcCtD
Epinephrine—Hyperglycaemia—Progesterone—uterine cancer	0.00129	0.00839	CcSEcCtD
Epinephrine—SLC22A1—renal system—uterine cancer	0.00127	0.0198	CbGeAlD
Epinephrine—Drowsiness—Progesterone—uterine cancer	0.00127	0.0083	CcSEcCtD
Epinephrine—ADRA2C—myometrium—uterine cancer	0.00127	0.0198	CbGeAlD
Epinephrine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00821	CcSEcCtD
Epinephrine—SLC22A5—myometrium—uterine cancer	0.00121	0.0189	CbGeAlD
Epinephrine—Local reaction—Epirubicin—uterine cancer	0.00118	0.00768	CcSEcCtD
Epinephrine—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00761	CcSEcCtD
Epinephrine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00752	CcSEcCtD
Epinephrine—Haemoglobin—Progesterone—uterine cancer	0.00115	0.00748	CcSEcCtD
Epinephrine—Haemorrhage—Progesterone—uterine cancer	0.00114	0.00745	CcSEcCtD
Epinephrine—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00741	CcSEcCtD
Epinephrine—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00737	CcSEcCtD
Epinephrine—Skin exfoliation—Etoposide—uterine cancer	0.00111	0.00724	CcSEcCtD
Epinephrine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00721	CcSEcCtD
Epinephrine—Local reaction—Doxorubicin—uterine cancer	0.00109	0.00711	CcSEcCtD
Epinephrine—ADRA1A—epithelium—uterine cancer	0.00104	0.0163	CbGeAlD
Epinephrine—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00678	CcSEcCtD
Epinephrine—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00675	CcSEcCtD
Epinephrine—ADRA2A—myometrium—uterine cancer	0.00101	0.0158	CbGeAlD
Epinephrine—Mental disorder—Progesterone—uterine cancer	0.000999	0.00652	CcSEcCtD
Epinephrine—Erythema—Progesterone—uterine cancer	0.000993	0.00648	CcSEcCtD
Epinephrine—ADRA2C—uterine cervix—uterine cancer	0.000987	0.0154	CbGeAlD
Epinephrine—ADRB1—female reproductive system—uterine cancer	0.000981	0.0153	CbGeAlD
Epinephrine—Tension—Progesterone—uterine cancer	0.000974	0.00636	CcSEcCtD
Epinephrine—ADRA1A—renal system—uterine cancer	0.000969	0.0151	CbGeAlD
Epinephrine—Nervousness—Progesterone—uterine cancer	0.000964	0.0063	CcSEcCtD
Epinephrine—SLC22A5—uterine cervix—uterine cancer	0.000945	0.0147	CbGeAlD
Epinephrine—ADRA2C—decidua—uterine cancer	0.00094	0.0146	CbGeAlD
Epinephrine—ADRA2C—renal system—uterine cancer	0.000923	0.0144	CbGeAlD
Epinephrine—SLC22A1—vagina—uterine cancer	0.000921	0.0144	CbGeAlD
Epinephrine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000906	0.00591	CcSEcCtD
Epinephrine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.0009	0.00587	CcSEcCtD
Epinephrine—ADRA2C—endometrium—uterine cancer	0.000892	0.0139	CbGeAlD
Epinephrine—SLC22A5—renal system—uterine cancer	0.000884	0.0138	CbGeAlD
Epinephrine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00576	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00088	0.00575	CcSEcCtD
Epinephrine—Palpitations—Progesterone—uterine cancer	0.000878	0.00573	CcSEcCtD
Epinephrine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000874	0.00571	CcSEcCtD
Epinephrine—ADRA2C—mammalian vulva—uterine cancer	0.000863	0.0135	CbGeAlD
Epinephrine—Hypertension—Progesterone—uterine cancer	0.000857	0.0056	CcSEcCtD
Epinephrine—SLC22A5—endometrium—uterine cancer	0.000855	0.0133	CbGeAlD
Epinephrine—Chest pain—Progesterone—uterine cancer	0.000845	0.00552	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00084	0.00548	CcSEcCtD
Epinephrine—Necrosis—Epirubicin—uterine cancer	0.00083	0.00542	CcSEcCtD
Epinephrine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000827	0.0054	CcSEcCtD
Epinephrine—ADRA2C—uterus—uterine cancer	0.000822	0.0128	CbGeAlD
Epinephrine—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.000814	0.00532	CcSEcCtD
Epinephrine—CYP1A2—renal system—uterine cancer	0.000801	0.0125	CbGeAlD
Epinephrine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.00519	CcSEcCtD
Epinephrine—Nervous system disorder—Progesterone—uterine cancer	0.000795	0.00519	CcSEcCtD
Epinephrine—Tachycardia—Progesterone—uterine cancer	0.000791	0.00516	CcSEcCtD
Epinephrine—ADRA2A—uterine cervix—uterine cancer	0.000787	0.0123	CbGeAlD
Epinephrine—Skin disorder—Progesterone—uterine cancer	0.000787	0.00514	CcSEcCtD
Epinephrine—Hyperhidrosis—Progesterone—uterine cancer	0.000783	0.00511	CcSEcCtD
Epinephrine—Necrosis—Doxorubicin—uterine cancer	0.000768	0.00501	CcSEcCtD
Epinephrine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000766	0.005	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000761	0.00497	CcSEcCtD
Epinephrine—ADRA2A—decidua—uterine cancer	0.00075	0.0117	CbGeAlD
Epinephrine—Flushing—Dactinomycin—uterine cancer	0.000748	0.00489	CcSEcCtD
Epinephrine—Extravasation—Epirubicin—uterine cancer	0.000747	0.00487	CcSEcCtD
Epinephrine—Insomnia—Progesterone—uterine cancer	0.000733	0.00479	CcSEcCtD
Epinephrine—Paraesthesia—Progesterone—uterine cancer	0.000728	0.00475	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Epirubicin—uterine cancer	0.000721	0.00471	CcSEcCtD
Epinephrine—Somnolence—Progesterone—uterine cancer	0.00072	0.0047	CcSEcCtD
Epinephrine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.0047	CcSEcCtD
Epinephrine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000717	0.00468	CcSEcCtD
Epinephrine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000713	0.00466	CcSEcCtD
Epinephrine—ADRA2A—endometrium—uterine cancer	0.000712	0.0111	CbGeAlD
Epinephrine—Sweating increased—Etoposide—uterine cancer	0.00071	0.00464	CcSEcCtD
Epinephrine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.00463	CcSEcCtD
Epinephrine—SLC22A5—female reproductive system—uterine cancer	0.000708	0.011	CbGeAlD
Epinephrine—Erythema—Dactinomycin—uterine cancer	0.000702	0.00458	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Progesterone—uterine cancer	0.0007	0.00457	CcSEcCtD
Epinephrine—Extravasation—Doxorubicin—uterine cancer	0.000691	0.00451	CcSEcCtD
Epinephrine—ADRA2A—mammalian vulva—uterine cancer	0.000689	0.0107	CbGeAlD
Epinephrine—ADRA2C—female gonad—uterine cancer	0.000673	0.0105	CbGeAlD
Epinephrine—ADRA2C—vagina—uterine cancer	0.000669	0.0104	CbGeAlD
Epinephrine—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.000667	0.00436	CcSEcCtD
Epinephrine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.00434	CcSEcCtD
Epinephrine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000659	0.0043	CcSEcCtD
Epinephrine—ADRA2A—uterus—uterine cancer	0.000656	0.0102	CbGeAlD
Epinephrine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000653	0.00426	CcSEcCtD
Epinephrine—SLC22A5—female gonad—uterine cancer	0.000644	0.01	CbGeAlD
Epinephrine—Acute coronary syndrome—Etoposide—uterine cancer	0.000641	0.00418	CcSEcCtD
Epinephrine—SLC22A5—vagina—uterine cancer	0.00064	0.00998	CbGeAlD
Epinephrine—Renal failure—Etoposide—uterine cancer	0.000639	0.00417	CcSEcCtD
Epinephrine—Myocardial infarction—Etoposide—uterine cancer	0.000637	0.00416	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000634	0.00414	CcSEcCtD
Epinephrine—Skin exfoliation—Epirubicin—uterine cancer	0.000622	0.00406	CcSEcCtD
Epinephrine—CYP2C9—female reproductive system—uterine cancer	0.000609	0.00949	CbGeAlD
Epinephrine—ADRA2A—female reproductive system—uterine cancer	0.00059	0.00919	CbGeAlD
Epinephrine—Hypoaesthesia—Etoposide—uterine cancer	0.000581	0.00379	CcSEcCtD
Epinephrine—Pulmonary oedema—Epirubicin—uterine cancer	0.00058	0.00379	CcSEcCtD
Epinephrine—CYP3A4—renal system—uterine cancer	0.00058	0.00903	CbGeAlD
Epinephrine—Skin exfoliation—Doxorubicin—uterine cancer	0.000575	0.00376	CcSEcCtD
Epinephrine—Flushing—Etoposide—uterine cancer	0.000542	0.00354	CcSEcCtD
Epinephrine—ADRA2A—female gonad—uterine cancer	0.000537	0.00836	CbGeAlD
Epinephrine—Pulmonary oedema—Doxorubicin—uterine cancer	0.000536	0.0035	CcSEcCtD
Epinephrine—Dizziness—Progesterone—uterine cancer	0.000536	0.0035	CcSEcCtD
Epinephrine—ADRA2A—vagina—uterine cancer	0.000533	0.00831	CbGeAlD
Epinephrine—Vomiting—Progesterone—uterine cancer	0.000515	0.00336	CcSEcCtD
Epinephrine—Renal impairment—Epirubicin—uterine cancer	0.000497	0.00324	CcSEcCtD
Epinephrine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00317	CcSEcCtD
Epinephrine—Hypoglycaemia—Epirubicin—uterine cancer	0.000485	0.00316	CcSEcCtD
Epinephrine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000483	0.00315	CcSEcCtD
Epinephrine—Nausea—Progesterone—uterine cancer	0.000481	0.00314	CcSEcCtD
Epinephrine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.00305	CcSEcCtD
Epinephrine—CYP3A4—female reproductive system—uterine cancer	0.000464	0.00724	CbGeAlD
Epinephrine—Renal impairment—Doxorubicin—uterine cancer	0.00046	0.003	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000448	0.00293	CcSEcCtD
Epinephrine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000446	0.00291	CcSEcCtD
Epinephrine—Hypertension—Etoposide—uterine cancer	0.000439	0.00286	CcSEcCtD
Epinephrine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000436	0.00285	CcSEcCtD
Epinephrine—Chest pain—Etoposide—uterine cancer	0.000432	0.00282	CcSEcCtD
Epinephrine—ADRA2C—lymph node—uterine cancer	0.000432	0.00674	CbGeAlD
Epinephrine—Hypokalaemia—Epirubicin—uterine cancer	0.00043	0.00281	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00043	0.0028	CcSEcCtD
Epinephrine—SLC22A5—lymph node—uterine cancer	0.000414	0.00645	CbGeAlD
Epinephrine—Tachycardia—Etoposide—uterine cancer	0.000405	0.00264	CcSEcCtD
Epinephrine—Skin disorder—Etoposide—uterine cancer	0.000403	0.00263	CcSEcCtD
Epinephrine—Hyperhidrosis—Etoposide—uterine cancer	0.000401	0.00262	CcSEcCtD
Epinephrine—Hypokalaemia—Doxorubicin—uterine cancer	0.000398	0.0026	CcSEcCtD
Epinephrine—Paraesthesia—Etoposide—uterine cancer	0.000372	0.00243	CcSEcCtD
Epinephrine—Hyperglycaemia—Epirubicin—uterine cancer	0.000369	0.00241	CcSEcCtD
Epinephrine—Somnolence—Etoposide—uterine cancer	0.000369	0.00241	CcSEcCtD
Epinephrine—Drowsiness—Epirubicin—uterine cancer	0.000364	0.00238	CcSEcCtD
Epinephrine—Vomiting—Dactinomycin—uterine cancer	0.000364	0.00238	CcSEcCtD
Epinephrine—Renal failure—Epirubicin—uterine cancer	0.000358	0.00234	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000358	0.00234	CcSEcCtD
Epinephrine—Sweating—Epirubicin—uterine cancer	0.000349	0.00228	CcSEcCtD
Epinephrine—ADRA2A—lymph node—uterine cancer	0.000345	0.00538	CbGeAlD
Epinephrine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000341	0.00223	CcSEcCtD
Epinephrine—Nausea—Dactinomycin—uterine cancer	0.00034	0.00222	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—uterine cancer	0.000337	0.0022	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—uterine cancer	0.000331	0.00216	CcSEcCtD
Epinephrine—Haemoglobin—Epirubicin—uterine cancer	0.000329	0.00215	CcSEcCtD
Epinephrine—Haemorrhage—Epirubicin—uterine cancer	0.000327	0.00214	CcSEcCtD
Epinephrine—Hypoaesthesia—Epirubicin—uterine cancer	0.000325	0.00212	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—uterine cancer	0.000323	0.00211	CcSEcCtD
Epinephrine—Haemoglobin—Doxorubicin—uterine cancer	0.000304	0.00199	CcSEcCtD
Epinephrine—Flushing—Epirubicin—uterine cancer	0.000304	0.00198	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—uterine cancer	0.000303	0.00198	CcSEcCtD
Epinephrine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000301	0.00197	CcSEcCtD
Epinephrine—Arrhythmia—Epirubicin—uterine cancer	0.000292	0.00191	CcSEcCtD
Epinephrine—Mental disorder—Epirubicin—uterine cancer	0.000287	0.00187	CcSEcCtD
Epinephrine—Erythema—Epirubicin—uterine cancer	0.000285	0.00186	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—uterine cancer	0.000281	0.00183	CcSEcCtD
Epinephrine—Tension—Epirubicin—uterine cancer	0.000279	0.00182	CcSEcCtD
Epinephrine—Nervousness—Epirubicin—uterine cancer	0.000277	0.00181	CcSEcCtD
Epinephrine—Dizziness—Etoposide—uterine cancer	0.000274	0.00179	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—uterine cancer	0.00027	0.00177	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—uterine cancer	0.000265	0.00173	CcSEcCtD
Epinephrine—Vomiting—Etoposide—uterine cancer	0.000264	0.00172	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—uterine cancer	0.000263	0.00172	CcSEcCtD
Epinephrine—Agitation—Epirubicin—uterine cancer	0.000262	0.00171	CcSEcCtD
Epinephrine—Tension—Doxorubicin—uterine cancer	0.000259	0.00169	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—uterine cancer	0.000256	0.00167	CcSEcCtD
Epinephrine—Palpitations—Epirubicin—uterine cancer	0.000252	0.00164	CcSEcCtD
Epinephrine—Nausea—Etoposide—uterine cancer	0.000246	0.00161	CcSEcCtD
Epinephrine—Hypertension—Epirubicin—uterine cancer	0.000246	0.0016	CcSEcCtD
Epinephrine—Chest pain—Epirubicin—uterine cancer	0.000242	0.00158	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—uterine cancer	0.000242	0.00158	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000241	0.00157	CcSEcCtD
Epinephrine—Palpitations—Doxorubicin—uterine cancer	0.000233	0.00152	CcSEcCtD
Epinephrine—Nervous system disorder—Epirubicin—uterine cancer	0.000228	0.00149	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—uterine cancer	0.000227	0.00149	CcSEcCtD
Epinephrine—Tachycardia—Epirubicin—uterine cancer	0.000227	0.00148	CcSEcCtD
Epinephrine—Skin disorder—Epirubicin—uterine cancer	0.000226	0.00147	CcSEcCtD
Epinephrine—Hyperhidrosis—Epirubicin—uterine cancer	0.000225	0.00147	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—uterine cancer	0.000224	0.00146	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000223	0.00145	CcSEcCtD
Epinephrine—Nervous system disorder—Doxorubicin—uterine cancer	0.000211	0.00138	CcSEcCtD
Epinephrine—Insomnia—Epirubicin—uterine cancer	0.00021	0.00137	CcSEcCtD
Epinephrine—Tachycardia—Doxorubicin—uterine cancer	0.00021	0.00137	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—uterine cancer	0.000209	0.00136	CcSEcCtD
Epinephrine—Paraesthesia—Epirubicin—uterine cancer	0.000209	0.00136	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000208	0.00136	CcSEcCtD
Epinephrine—Somnolence—Epirubicin—uterine cancer	0.000207	0.00135	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000201	0.00131	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—uterine cancer	0.000194	0.00127	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—uterine cancer	0.000193	0.00126	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—uterine cancer	0.000191	0.00125	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000186	0.00121	CcSEcCtD
Epinephrine—Dizziness—Epirubicin—uterine cancer	0.000154	0.001	CcSEcCtD
Epinephrine—Vomiting—Epirubicin—uterine cancer	0.000148	0.000965	CcSEcCtD
Epinephrine—Dizziness—Doxorubicin—uterine cancer	0.000142	0.000928	CcSEcCtD
Epinephrine—Nausea—Epirubicin—uterine cancer	0.000138	0.000901	CcSEcCtD
Epinephrine—Vomiting—Doxorubicin—uterine cancer	0.000137	0.000893	CcSEcCtD
Epinephrine—Nausea—Doxorubicin—uterine cancer	0.000128	0.000834	CcSEcCtD
Epinephrine—ADRA2A—Signaling Pathways—CDKN2B—uterine cancer	1.38e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—KRAS—uterine cancer	1.38e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EP300—uterine cancer	1.37e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ESR1—uterine cancer	1.37e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SMAD3—uterine cancer	1.35e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ESR1—uterine cancer	1.35e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—AKT1—uterine cancer	1.34e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1R—uterine cancer	1.34e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—PIK3CA—uterine cancer	1.34e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ESR1—uterine cancer	1.34e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCL8—uterine cancer	1.33e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL2—uterine cancer	1.32e-05	0.000156	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.31e-05	0.000155	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCL8—uterine cancer	1.3e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—uterine cancer	1.3e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—uterine cancer	1.29e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FGFR2—uterine cancer	1.29e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—NRAS—uterine cancer	1.29e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NRAS—uterine cancer	1.28e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—NRAS—uterine cancer	1.28e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—PIK3CA—uterine cancer	1.27e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ESR1—uterine cancer	1.26e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—NRAS—uterine cancer	1.26e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SMAD3—uterine cancer	1.26e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ESR1—uterine cancer	1.24e-05	0.000147	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—uterine cancer	1.24e-05	0.000147	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—PIK3CA—uterine cancer	1.23e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—uterine cancer	1.22e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—KRAS—uterine cancer	1.22e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCL8—uterine cancer	1.21e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL2—uterine cancer	1.2e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGFR2—uterine cancer	1.2e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—NRAS—uterine cancer	1.19e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL2—uterine cancer	1.19e-05	0.000141	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.19e-05	0.000141	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—STK11—uterine cancer	1.19e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL2—uterine cancer	1.18e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—NRAS—uterine cancer	1.18e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—uterine cancer	1.17e-05	0.000139	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—RRM2—uterine cancer	1.16e-05	0.000138	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—DCN—uterine cancer	1.13e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—PIK3CA—uterine cancer	1.12e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PIK3CA—uterine cancer	1.12e-05	0.000133	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.11e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—PIK3CA—uterine cancer	1.11e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL2—uterine cancer	1.11e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—KRAS—uterine cancer	1.11e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KRAS—uterine cancer	1.11e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ESR1—uterine cancer	1.1e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—KRAS—uterine cancer	1.1e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ERBB2—uterine cancer	1.1e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—PIK3CA—uterine cancer	1.1e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL2—uterine cancer	1.1e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—uterine cancer	1.09e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—KRAS—uterine cancer	1.09e-05	0.000129	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.06e-05	0.000126	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.06e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—NRAS—uterine cancer	1.04e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL8—uterine cancer	1.04e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—PIK3CA—uterine cancer	1.04e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—uterine cancer	1.04e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—uterine cancer	1.03e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—KRAS—uterine cancer	1.03e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ESR1—uterine cancer	1.03e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—PIK3CA—uterine cancer	1.02e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PIK3CA—uterine cancer	1.02e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN1B—uterine cancer	1.02e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PIK3CA—uterine cancer	1.02e-05	0.00012	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.00012	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—STK11—uterine cancer	1.01e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—KRAS—uterine cancer	1.01e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PIK3CA—uterine cancer	1.01e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—uterine cancer	1.01e-05	0.000119	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.01e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ERBB2—uterine cancer	1e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PIK3CA—uterine cancer	9.98e-06	0.000118	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ERBB2—uterine cancer	9.93e-06	0.000118	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—uterine cancer	9.83e-06	0.000116	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ERBB2—uterine cancer	9.8e-06	0.000116	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—uterine cancer	9.73e-06	0.000115	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTEN—uterine cancer	9.73e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	9.7e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CTNNB1—uterine cancer	9.62e-06	0.000114	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.52e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL8—uterine cancer	9.5e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTEN—uterine cancer	9.46e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PIK3CA—uterine cancer	9.45e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—uterine cancer	9.44e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL8—uterine cancer	9.42e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—uterine cancer	9.4e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PTEN—uterine cancer	9.38e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—uterine cancer	9.36e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL8—uterine cancer	9.3e-06	0.00011	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PIK3CA—uterine cancer	9.3e-06	0.00011	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN1B—uterine cancer	9.28e-06	0.00011	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ERBB2—uterine cancer	9.28e-06	0.00011	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—EP300—uterine cancer	9.28e-06	0.00011	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—uterine cancer	9.24e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1B—uterine cancer	9.2e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—uterine cancer	9.18e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—uterine cancer	9.15e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	9.13e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—uterine cancer	9.1e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	9.09e-06	0.000108	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.08e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1B—uterine cancer	9.08e-06	0.000108	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTEN—uterine cancer	9.07e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—uterine cancer	9.04e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—EP300—uterine cancer	9.02e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	8.99e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—uterine cancer	8.98e-06	0.000106	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EP300—uterine cancer	8.95e-06	0.000106	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—uterine cancer	8.92e-06	0.000106	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	8.8e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CTNNB1—uterine cancer	8.77e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	8.74e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	8.69e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	8.66e-06	0.000103	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—EP300—uterine cancer	8.65e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	8.6e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	8.59e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CTNNB1—uterine cancer	8.58e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTEN—uterine cancer	8.55e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	8.5e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—uterine cancer	8.47e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTEN—uterine cancer	8.47e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	8.45e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	8.45e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—uterine cancer	8.37e-06	9.92e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	8.36e-06	9.91e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTEN—uterine cancer	8.36e-06	9.91e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	8.35e-06	9.9e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—uterine cancer	8.34e-06	9.88e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—uterine cancer	8.3e-06	9.83e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	8.26e-06	9.79e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	8.26e-06	9.79e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—uterine cancer	8.16e-06	9.67e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EP300—uterine cancer	8.15e-06	9.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	8.12e-06	9.62e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	8.11e-06	9.61e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EP300—uterine cancer	8.08e-06	9.57e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	7.99e-06	9.47e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EP300—uterine cancer	7.97e-06	9.45e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTEN—uterine cancer	7.91e-06	9.37e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.86e-06	9.32e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—STK11—uterine cancer	7.83e-06	9.28e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.83e-06	9.28e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	7.79e-06	9.23e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—uterine cancer	7.72e-06	9.15e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	7.72e-06	9.15e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	7.69e-06	9.11e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTEN—uterine cancer	7.68e-06	9.11e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	7.67e-06	9.09e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	7.65e-06	9.06e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	7.64e-06	9.05e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—uterine cancer	7.62e-06	9.04e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—uterine cancer	7.62e-06	9.04e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	7.59e-06	9e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—uterine cancer	7.56e-06	8.95e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—uterine cancer	7.55e-06	8.95e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EP300—uterine cancer	7.54e-06	8.94e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	7.53e-06	8.93e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	7.51e-06	8.9e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—uterine cancer	7.46e-06	8.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	7.43e-06	8.8e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EP300—uterine cancer	7.42e-06	8.8e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—EP300—uterine cancer	7.33e-06	8.68e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—uterine cancer	7.2e-06	8.54e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	7.15e-06	8.47e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	7.14e-06	8.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	7.1e-06	8.41e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	7.09e-06	8.41e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—uterine cancer	7.06e-06	8.36e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	7.03e-06	8.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	6.98e-06	8.27e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	6.95e-06	8.23e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	6.92e-06	8.2e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	6.9e-06	8.18e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—uterine cancer	6.86e-06	8.13e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	6.75e-06	8e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.72e-06	7.96e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—uterine cancer	6.67e-06	7.91e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	6.62e-06	7.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EP300—uterine cancer	6.59e-06	7.82e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	6.59e-06	7.81e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—uterine cancer	6.56e-06	7.78e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—uterine cancer	6.5e-06	7.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	6.43e-06	7.61e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—uterine cancer	6.42e-06	7.61e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—uterine cancer	6.4e-06	7.59e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—uterine cancer	6.4e-06	7.58e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	6.27e-06	7.43e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	6.25e-06	7.4e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	6.17e-06	7.31e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EP300—uterine cancer	6.13e-06	7.26e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—uterine cancer	6.12e-06	7.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—uterine cancer	6.07e-06	7.2e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—uterine cancer	6.03e-06	7.15e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	5.98e-06	7.08e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	5.97e-06	7.08e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—uterine cancer	5.9e-06	6.99e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—uterine cancer	5.88e-06	6.97e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—uterine cancer	5.83e-06	6.91e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	5.8e-06	6.88e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—uterine cancer	5.78e-06	6.85e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	5.73e-06	6.79e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—uterine cancer	5.71e-06	6.76e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—uterine cancer	5.61e-06	6.64e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	5.58e-06	6.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—uterine cancer	5.58e-06	6.61e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—uterine cancer	5.53e-06	6.55e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	5.49e-06	6.51e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—uterine cancer	5.46e-06	6.47e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—uterine cancer	5.45e-06	6.46e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—uterine cancer	5.42e-06	6.42e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—uterine cancer	5.41e-06	6.41e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—uterine cancer	5.4e-06	6.4e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—uterine cancer	5.31e-06	6.3e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	5.31e-06	6.29e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—uterine cancer	5.22e-06	6.19e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—uterine cancer	5.16e-06	6.12e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	5.08e-06	6.02e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTEN—uterine cancer	4.96e-06	5.88e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	4.93e-06	5.85e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—uterine cancer	4.93e-06	5.84e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—uterine cancer	4.88e-06	5.78e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	4.88e-06	5.78e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—uterine cancer	4.82e-06	5.71e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—EP300—uterine cancer	4.73e-06	5.61e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—uterine cancer	4.72e-06	5.59e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—uterine cancer	4.56e-06	5.4e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	4.53e-06	5.37e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	4.51e-06	5.35e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	4.49e-06	5.32e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—uterine cancer	4.43e-06	5.25e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—uterine cancer	4.38e-06	5.2e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTEN—uterine cancer	4.24e-06	5.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	4.19e-06	4.97e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—EP300—uterine cancer	4.05e-06	4.79e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	3.99e-06	4.72e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	3.7e-06	4.39e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.5e-06	4.15e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTEN—uterine cancer	3.27e-06	3.88e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—EP300—uterine cancer	3.12e-06	3.7e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.99e-06	3.55e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—uterine cancer	2.86e-06	3.39e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—uterine cancer	2.44e-06	2.9e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—uterine cancer	1.89e-06	2.24e-05	CbGpPWpGaD
